From GlobeNewswire: 2024-06-25 10:00:00

The global Lung Cancer Surgery Market is projected to grow from $5.91 billion in 2023 to $9.92 billion by 2033, with a CAGR of 5.32%. Surgery is a key option for patients with localized lung cancer, using either thoracotomy or minimally invasive methods. Rising incidence of lung cancer worldwide is driving market growth, though high costs and post-surgery challenges remain obstacles. North America leads the market, with Asia Pacific expected to grow rapidly due to increased diagnoses and advanced healthcare facilities. Major vendors include Johnson & Johnson, Medrobotics Corporation, and Novartis AG. Medtronic recently conducted the first lung ablation procedure using the ILLUMISITE platform. This global market is segmented by device, procedure, and end-user, with regional analysis covering North America, Europe, Asia Pacific, and more. Other related reports cover global markets in Portable Ultrasound Machines, Robotic Dentistry, Breast Pumps, and Mental Health Screening. Spherical Insights & Consulting offers comprehensive market research and consulting services to provide actionable insights for businesses.



Read more at GlobeNewswire: Global Lung Cancer Surgery Market Size To Exceed USD 9.92